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ABSTRACT
To determine the frequency of smokeless tobacco use among young patients with acute ischemic stroke.
METHODS: This cross sectional study was conducted from April to September 2015at emergency department of
Aga khan university.A total of 135 patients presented with signs and symptoms of acute ischemic stroke were
included in this research. Participants were selected throughNon probability consecutive samplingtechnique.
SPSS 20 was used for data analysis.A predesigned proforma was ﬁlled. It has three parts including SocioDemographics, Factors for stroke like hypertension, diabetes Mellitus, dyslipidemia, cigarrete smoking and History
of smokeless tobacco use.Young stroke was deﬁned as patients between 20-49 years of age having symptoms of
acute ischemic stroke. Smokeless Tobacco users: An individual taking greater than and equal to 3 packets of
anyone among gutka, main puri and pan daily for the last two years, is a smokeless tobacco user.
RESULTS: There were 62.2% male and 37.78% were female. Hypertension (81.5%), diabetes mellitus (75.6%)
and dyslipidemia (63%) were observed that were commonly associated with stroke. Smoking habit was observed
in 17.04% (23/135) cases. Mean duration of smoking of these patients was 10.22±2.43 years and median number
of cigarettes smoked per day was5(IQR=2)
Frequency of smokeless chewable tobacco in the form of gutka, mainpuri and pan daily in the ischemic stroke
patients was found to be 28.15% (38/135) cases.Mean duration of smokeless chewable tobacco use was
7.55±2.79 years
CONCLUSION: Frequency of use of chewable tobacco products is high in acute ischemic stroke patients.
KEY WORDS: Acute ischemic stroke, Smokeless tobacco, Cigarrete smoking

INTRODUCTION:

riskof clot formation and subsequent stroke risk
through a slowed ﬂow or stasis phenomenon Oral and
nasal smokeless tobacco products have been used in
many countries for centuries. During most of the 20th
century, use of these products declined in Europe and
North America, but a reverse trend in prevalence of
use has been reported in the past few decades,
particularly among people younger than 40. [9]
Several studies were done to see association
between smokeless tobacco use and stroke.Metaanalysis from both the United States and Sweden
showed an increased risk of fatal myocardial
infarction and fatal stroke among users of smokeless
tobacco products compared with non-users.[10]
Two prospective studies of mortality among the use of
chewing tobacco[11] done in United States, provide
evidence that current use of spit tobacco was
statistically signiﬁcantly associated with death from

Stroke in young has emerged as a major public health
problem in Pakistan. Several hospital based studies
have revealed relatively high proportion of young
stroke.
Tobacco use is a risk factor for atherosclerosis.
Stroke-related morbidity stems from the fact that
tobacco contains over 4000 different chemicals
including heavy metals and other toxins that promote
the development of free radicals, inducing vascular
endothelial dysfunction and inﬂammation, ultimately
leading to the development and acceleration of the
atherosclerotic process. Tobacco also causes the
development of a global circulatory procoagulant
state thought to be induced by altered hemostatic and
inﬂammatory marker concentrations. It decreases
cerebral blood ﬂow, which may further increase the
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tobacco use, to control the effect of modiﬁer by
applying chi square, taking p value ≤0.05 as
signiﬁcant.

coronary heart disease (CHD), stroke, and diseases of
the respiratory, digestive, and genitourinary systems,
but not with death from cancer. Recent study among
the adolescents and adults of Karachi squatter
settlement reported that 40% of the population was
using at least one chewable product of betel, areca and
tobacco on a daily basis.14
The purpose of this study is to determine the frequency
of smokeless tobacco use in acute ischemic stroke in
young patients so that strategies can be made for
further research in this respect and to improve the
quality of care we provide to these patients.

RESULTS:
A total of 135 patients presented to ER with signs and
symptoms of acute ischemic stroke were included
inthis research. There were 62.2% male and 37.78%
were female.Hypertension (81.5%), diabetes mellitus
(75.6%) and dyslipidemia (63%) were observed that
were commonly associated with stroke.
Smoking habit was observed in 17.04% (23/135)
cases. Mean duration of smoking of these patients was
10.22±2.43 years and median number of cigarettes
smoked per day was 5(IQR=2) In this study, frequency
of smokeless chewable tobacco in the form of gutka,
mainpuri and pan daily in the ischemic stroke patients
was found to be 28.15% (38/135) cases. Mean
duration of smokeless chewable tobacco use was
7.55±2.79 years. Rate of smokeless chewable
tobacco was high in male cases as compare to female
cases (35.7% vs. 15.7%)

MATERIALS AND METHODS:
This Cross-sectional study was conducted from April to
September 2015 in the Aga Khan University Hospital
Karachi. The sample size was calculated by using the
WHO sample size calculator, taking the frequency of
smokeless tobacco in ischemic stroke patient as 22%
15 and margin of error 7% with the conﬁdence interval
of 95% than the estimated sample size was 135
patients with acute ischemic stroke.
Sample was collected through non probability
consecutive sampling.
Patients age between 20-49 years, bothmale and
female presented to emergency with signs and
symptoms of acute ischemic stroke and conﬁrmation
of ischemia on MRI brain were included. Thosewho will
have acute stroke due to intra cerebral bleed or
subarachnoid hemorrhage were excluded. Also
excluded were those who were not willing to participate
in the study or transferred out to other hospitals from
emergency room.
Informed consent from the patient or attendant was
obtained. Patients were recruited, who fulﬁll the
inclusion criteria. A predesigned proforma (attached as
annexure) was ﬁlled out for each patient consenting to
participate in this study. It has three parts including
Socio-Demographics, Factors for stroke like
hypertension, diabetes Mellitus, dyslipidemia,
cigarrete smoking and History of smokeless tobacco
use.
The collected information was entered in the SPSS
version 19 and analyzed through its statistical
package. Quantitative variable that is age, duration of
cigarette smoking and smokeless tobacco use was
presented as mean with standard deviation.
Qualitative variables were gender, Hypertension,
Diabetes Mellitus, dyslipidemia and outcome variable
in ischemic stroke patients that is the presence and
absence of history of smokeless tobacco use was
calculated in terms of frequency and percentage.
Stratiﬁcation was done with regards to age, gender,
factors predisposing to smokeless tobacco use i:e
educational status, occupation, factors of stroke like
hypertension/diabetes/dyslipidemia and comparison
with the outcome variable i.e. history of smokeless
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DISCUSSION:
In Pakistan and South Asian subcontinent, the popular
chewing products are paan, chaalia, gutka, niswar and
tumbaku[21]. The composition of these products may
vary from one to another but the main ingredients
remain betel, areca and tobacco. Paan contains areca
nut, betel leaf and calcium hydroxide but tobacco and
various other spices are also commonly added[22].
Industrially prepared mixture of areca nut, lime,
catechin containing substance, sandalwood fragrance
with tobacco (gutka) or without tobacco (chaalia) were
introduced in recent decades, which have contributed
to growth and use of these products.[23]In Pakistan, a
recent study among the adolescents and adults of a
Karachi squatter settlement reported that 40% of the
population was using at least one chewable product of
betel, areca and tobacco on daily basis. [20,14]
Among the established vascular risk factors for stroke,
hypertension is the single most important modiﬁable
risk factor for both ischemic and hemorrhagic stroke
[26]. Kamal et al. noted hypertension in 64% of stroke
patients in their multiethnic community-based survey
[27]In our study we foundhypertensionin 81.5% of
stroke patients.
In our study, frequency of smokeless chewable
tobacco in the form of gutka, mainpuri and pan daily in
the young ischemic stroke patients was found to be
28.15% (38/135). Mean duration of smokeless
chewable tobacco use was 7.55±2.79 years. In one
study of Pakistan, frequency of chewable tobacco in
the form of pan, gutka or supari (locally available forms
with areca and betel nut) in the ischemic stroke
patients was found to be 22%15.
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CONCLUSION:
Frequency of use of chewable products is high in
ischemic stroke patients. Industrially prepared
products, chaalia and gutka, are gaining popularity
among the youth and it can cause a signiﬁcant health
burden on the community. Strategies can be made for
further research in this respect and to improve the
quality of care we provide to these patients.
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